Skip to content

Press Release · Press Releases

MetaVia Announces Statistically Significant 68% Reduction in Liver Fat from DA-1726 Phase 1 Part 3B Interim Data

Issued by PR Newswire

Image: PR Newswire

DA-1726 Also Demonstrated Statistically Significant 13.5% Placebo-Adjusted Weight Loss and Reduced Mean HbA1c from 5.79% to 5.33% in Participants Without Diabetes No New Gastrointestinal Adverse Events Were Reported After Week 9 Through Day 109, with No Gastrointestinal Adverse Events...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories

Press Release

Midwestern City Lights

City lights from the Midwestern United States to the East Coast sparkle across the landscape a couple of hours before sunrise on Oct. 18, 2026. Major urban areas visible in the photograph include Chicago, Illinois; Detroit, Michigan; and the New York metropolitan region. The International Space Station was orbiting 259 miles above Earth when this […]

NASA ·

Press Release

NASA Astronauts to Answer Questions from Florida Students

Students in Florida will hear from NASA astronauts Jessica Watkins and Luke Delaney as they answer prerecorded STEM questions while aboard the International Space Station. The Earth-to-space call will begin at 10:40 a.m. EST Tuesday, Nov. 10, and will stream live on the agency’s Learn With NASA YouTube channel. This event is hosted by Freedom Crossing Academy in […]

NASA ·